In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding and there are 3 ways to measure performance in patient-centered outcomes research.
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding to determine whether levels should be adjusted in autumn 2019. And now researchers are analyzing work in patient-centered outcomes research to ascertain how well the work is being done and what might be done better, according to a new commentary from RAND.
The Patient-Centered Outcomes Research Institute, established in 2010, has funded hundreds of studies and Thomas W. Concannon, senior policy researcher at RAND, highlights 3 ways to measure performance in patient-centered outcomes research:
Read the full commentary at RAND.
Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control
July 3rd 2025Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.
Read More